In this interview, News-Medical talks to Mr. Byrne about the crucial role of analytical services.
CDMOs Nephron and Canton each raise hundreds of millions in financing
Nephron Pharmaceuticals and Canton Biologics recently announced capital raises totaling hundreds of millions of dollars, joining the growing market for contract and development manufacturing companies.